EVOTAZ 300 mg / 150 mg film-coated tablets
- Licence status
- Active substances
- Atazanavir, Cobicistat
- Dosage Form
- Film-coated tablet
- Licence number
- EU/1/15/1025/001-002
- Licence holder
- Bristol-Myers Squibb Pharma EEIG
Product documents
Licence information
- ATC code
- J05AR Antivirals for treatment of HIV infections, combinations, J05AR15 atazanavir and cobicistat
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 13/07/2015